The DOI matches its Crossref record; 285 of the 285 references it cites were found in a registry or an index.
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Open accessAbstract
The European Respiratory Society (ERS)/European Society of Thoracic Surgeons (ESTS)/European Association for Cardio-Thoracic Surgery (EACTS)/European Society for Radiotherapy and Oncology (ESTRO) task force brought together experts to update previous 2009 ERS/ESTS guidelines on management of malignant pleural mesothelioma (MPM), a rare cancer with globally poor outcome, after a systematic review of the 2009–2018 literature. The evidence was appraised using the Grading of Recommendations, Assessment, Development and Evaluation approach. The evidence syntheses were discussed and recommendations formulated by this multidisciplinary group of experts. Diagnosis: pleural biopsies remain the gold standard to confirm the diagnosis, usually obtained by thoracoscopy but occasionally via image-guided percutaneous needle biopsy in cases of pleural symphysis or poor performance status. Pathology: standard staining procedures are insufficient in ∼10% of cases, justifying the use of specific markers, including BAP-1 and CDKN2A(p16) for the separation of atypical mesothelial proliferation from MPM. Staging: in the absence of a uniform, robust and validated staging system, we advise using the most recent 2016 8th TNM (tumour, node, metastasis) classification, with an algorithm for pre-therapeutic assessment. Monitoring: patient's performance status, histological subtype and tumour volume are the main prognostic factors of clinical importance in routine MPM management. Other potential parameters should be recorded at baseline and reported in clinical trials. Treatment: (chemo)therapy has limited efficacy in MPM patients and only selected patients are candidates for radical surgery. New promising targeted therapies, immunotherapies and strategies have been reviewed. Because of limited data on the best combination treatment, we emphasise that patients who are considered candidates for a multimodal approach, including radical surgery, should be treated as part of clinical trials in MPM-dedicated centres.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–285 of 285
Pleural mesothelioma mortality and asbestos exposure mapping in Italy
Fazzo, L., Santis, M. D., Minelli, G., Bruno, C., Zona, A., Marinaccio, A., Conti, S., & Comba, P. (2011) · American Journal of Industrial Medicine · doi:10.1002/ajim.21015 · Cited by 49
Vermiculite Worker Mortality: Estimated Effects of Occupational Exposure to Libby Amphibole
Larson, T. C., III, Antao, V. C., & Bove, F. (2010) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e3181dc6d45 · Cited by 48
Pleural cancer mortality in Spain: time-trends and updating of predictions up to 2020
López‐Abente, G., Gómez, M. G., Navarro, A. M., Fernández‐Navarro, P., Ramis, R., García‐Pérez, J., Cervantes-Amat, M., Ferreras, E., Jiménez-Muñoz, M., & Pastor‐Barriuso, R. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-528 · Cited by 48
Cheung, M., Kadariya, Y., Talarchek, J. N., Pei, J., Ohar, J. A., Kayaleh, O. R., & Testa, J. R. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.09.011 · Cited by 48
Gube, M., Taeger, D., Weber, D. G., Pesch, B., Brand, P., Johnen, G., Müller-Lux, A., Gross, I. M., Wiethege, T., Weber, A., et al. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0580-2 · Cited by 46
Arrieta, O. G., Medina, L. A., Estrada-Lobato, E., Hernández‐Pedro, N., Villanueva‐Rodriguez, G. M., Martínez-Barrera, L. M., Macedo, E. O., López‐Rodríguez, V., Motola‐Kuba, D., & Corona-Cruz, J. F. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.44 · Cited by 46
O'Brien, M. E. R., Gaafar, R. M., Popat, S., Grossi, F., Price, A., Talbot, D. C., Čufer, T., Ottensmeier, C. H. H., Danson, S. J., Pallis, A. G., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.05.008 · Cited by 45
de Klerk, N., Alfonso, H., Olsen, N., Reid, A., Sleith, J., Palmer, L., Berry, G., & Musk, A. (. (2013) · International Journal of Cancer · doi:10.1002/ijc.27758 · Cited by 45
Effectiveness of mesothelin family proteins and osteopontin for malignant mesothelioma
Pantazopoulos, I. N., Boura, P., Xanthos, T. T., & Syrigos, K. (2012) · European Respiratory Journal · doi:10.1183/09031936.00226111 · Cited by 44
Andujar, P., Pairon, J. ‐., Renier, A., Descatha, A., Hysi, I., Abd‐Alsamad, I., Billon‐Galland, M., Blons, H., Clin, B., Danel, C. J., et al. (2013) · Mutagenesis · doi:10.1093/mutage/get008 · Cited by 43
Self-citationBuikhuisen, W. A., Scharpfenecker, M., Griffioen, A. W., Korse, C. M., van Tinteren, H., & Baas, P. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.01.014 · Cited by 43
Demir, M., Kaya, H., Taylan, M., Ekinci, A., Yılmaz, S., Teke, F., Sezgı, C., Tanrıkulu, A. Ç., Meteroğlu, F., & Şenyiğit, A. (2016) · Lung · doi:10.1007/s00408-016-9868-1 · Cited by 43
High risk of malignant mesothelioma and pleural plaques in subjects born close to ophiolites
Bayram, M., Dongel, I., Bakan, N. D., Yalççn, H., Cevit, R., Dumortier, P., & Nemery, B. (2013) · Chest · doi:10.1378/chest.11-2727 · Cited by 42
Soeberg, M., Leigh, J., Driscoll, T., Armstrong, B. K., Young, J. M., & van Zandwijk, N. (2016) · Occupational and Environmental Medicine · doi:10.1136/oemed-2015-103309 · Cited by 42
Assessment of cancer risks due to environmental exposure to asbestos
Driece, H. A. L., Siesling, S., Swuste, P. H. J. J., & Burdorf, A. (2010) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/jes.2009.56 · Cited by 41
Are pleural plaques an appropriate endpoint for risk analyses?
Maxim, L. D., Niebo, R., & Utell, M. J. (2015) · Inhalation Toxicology · doi:10.3109/08958378.2015.1051640 · Cited by 41
Kovač, V., Zwitter, M., Rajer, M., Marin, A., Debeljak, A., Smrdel, U., & Vrankar, M. (2011) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32834d7a1c · Cited by 41
Gene–asbestos interaction in malignant pleural mesothelioma susceptibility
Tùnesi, S., Ferrante, D., Mirabelli, D., Andorno, S., Betti, M., Fiorito, G., Guarrera, S., Casalone, E., Neri, M., Ugolini, D., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv097 · Cited by 41
Hollevoet, K., Cleemput, J. V., Thimpont, J., Vuyst, P. D., Bosquée, L., Nackaerts, K., Germonpré, P. R., Vansteelandt, S., Kishi, Y., Delanghe, J., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31820db377 · Cited by 40
Pei, D., Li, Y., Liu, X., Yan, S., Guo, X., Xu, X., & Guo, X. (2017) · Oncotarget · doi:10.18632/oncotarget.14712 · Cited by 40
Mirabelli, D., Cavone, D., Merler, E., Gennaro, V., Romanelli, A., Mensi, C., Chellini, E., Nicita, C., Marinaccio, A., Magnani, C., et al. (2010) · Occupational and Environmental Medicine · doi:10.1136/oem.2009.047019 · Cited by 39
Wheatley‐Price, P., Chu, Q. S.-C., Bonomi, M., Seely, J. M., Gupta, A. K., Goss, G. D., Hilton, J. F., Feld, R. D., Lee, C. W., Goffin, J. R., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.06.024 · Cited by 39
Incidence of malignant mesothelioma in Germany 2009–2013
Lehnert, M., Kraywinkel, K., Heinze, E., Wiethege, T., Johnen, G., Fiebig, J., Brüning, T., & Taeger, D. (2016) · Cancer Causes & Control · doi:10.1007/s10552-016-0838-y · Cited by 39
NLRP1 polymorphisms in patients with asbestos-associated mesothelioma
Girardelli, M., Maestri, I., Rinaldi, R., Tognon, M. G., Boldorini, R. L., Bovenzi, M., Crovella, S., & Comar, M. (2012) · Infectious Agents and Cancer · doi:10.1186/1750-9378-7-25 · Cited by 36
Bayram, M., Döngel, İ., Akbaş, A., Benli, İ., Akkoyunlu, M. E., & Bakan, N. D. (2013) · Lung · doi:10.1007/s00408-013-9526-9 · Cited by 35
Tse, L. A., Yu, I. T.-S., Goggins, W. B., Clements, M., Wang, X. R., Au, J. S. K., & Yu, K. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.0900868 · Cited by 35
Felten, M. K., Khatab, K., Knoll, L., Schettgen, T., Müller-Berndorff, H., & Kraus, T. (2013) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-013-0853-1 · Cited by 35
Goldberg, S., Rey, G., Luce, D., Ilg, A. G. S., Rolland, P., Brochard, P., Imbernon, E., & Goldberg, M. (2010) · Occupational and Environmental Medicine · doi:10.1136/oem.2009.050336 · Cited by 35
Staging algorithm for diffuse malignant pleural mesothelioma☆
Zieliński, M., Hauer, J., Hauer, Ł., et al. (2009) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1510/icvts.2009.213611 · Cited by 35
Familial malignant mesothelioma: A population-based study in Central Italy (1980–2012)
Ascoli, V., Romeo, E., Scalzo, C. C., Cozzi, I., Ancona, L., Cavariani, F., Balestri, A., Gasperini, L., & Forastiere, F. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2014.02.014 · Cited by 34
A decade of malignant mesothelioma surveillance in Korea
Jung, S., Kim, H., Koh, S. B., Yong, S., Chung, M. J., Lee, C. H., Han, J., Eom, M., & Oh, S. (2012) · American Journal of Industrial Medicine · doi:10.1002/ajim.22065 · Cited by 33
Radical multimodality therapy for malignant pleural mesothelioma
Abdel-Rahman, O. M., Elsayed, Z., Mohamed, H. H., & Eltobgy, M. M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012605.pub2 · Cited by 33
Regional variations in German mesothelioma mortality rates: 2000–2010
Schonfeld, S. J., McCormack, V., Rutherford, M. J., & Schüz, J. (2014) · Cancer Causes & Control · doi:10.1007/s10552-014-0368-4 · Cited by 32
Mortality experience among Minnesota taconite mining industry workers
Allen, E. M., Alexander, B. H., MacLehose, R. F., Ramachandran, G., & Mandel, J. H. (2014) · Occupational and Environmental Medicine · doi:10.1136/oemed-2013-102000 · Cited by 32
Data Quality in Rare Cancers Registration: The Report of the RARECARE Data Quality Study
Trama, A., Marcos‐Gragera, R., Pérez, M. J. S., van der Zwan, J. M., Ardanáz, E., Bouchardy, C., Rodríguez, J. M. M., Martínez, C., Capocaccia, R., Vicentini, M., et al. (2016) · Tumori Journal · doi:10.5301/tj.5000559 · Cited by 32
Krug, L. M., Woźniak, A., Kindler, H. L., Feld, R. D., Koczywas, M., Morero, J. L., Rodriguez, C. P., Ross, H. J., Bauman, J. E., Орлов, С. В., et al. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.06.008 · Cited by 31
Lung cancer and mesothelioma risk assessment for a population environmentally exposed to asbestos
Bourgault, M.-H., Gagné, M., & Valcke, M. (2014) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2013.07.008 · Cited by 30
Tarrés, J., Albertí, C., Martínez-Artés, X., Abós-Herràndiz, R., Rosell-Murphy, M., García-Allas, I., Krier, I., Cantarell, G., Gallego, M., Canela-Soler, J., et al. (2013) · Occupational and Environmental Medicine · doi:10.1136/oemed-2012-101198 · Cited by 30
Malignant mesothelioma incidence among talc miners and millers in New York State
Finkelstein, M. M. (2012) · American Journal of Industrial Medicine · doi:10.1002/ajim.22063 · Cited by 30
A case–control study of mesothelioma in Minnesota iron ore (taconite) miners
Lambert, C., Alexander, B. H., Ramachandran, G., MacLehose, R. F., Nelson, H. H., Ryan, A. D., & Mandel, J. H. (2015) · Occupational and Environmental Medicine · doi:10.1136/oemed-2015-103105 · Cited by 30
Helland, Å., Solberg, S. K., & Brustugun, O. T. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318275b346 · Cited by 29
Tourkantonis, I., Makrilia, N., Ralli, M. L., Alamara, C. V., Nikolaidis, I., Tsimpoukis, S., Charpidou, A. G., Kotanidou, A. N., & Syrigos, K. (2010) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3181cae90e · Cited by 29
Estimated future incidence of malignant mesothelioma in South Korea: Projection from 2014 to 2033
Kwak, K., Paek, D., Hwang, S.-S., & Ju, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183404 · Cited by 29
Pintos, J., Parent, M., Case, B. W., Rousseau, M., & Siemiatycki, J. (2009) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e3181b68cef · Cited by 28
Soeberg, M., Creighton, N., Currow, D. C., Young, J. M., & van Zandwijk, N. (2015) · Australian and New Zealand Journal of Public Health · doi:10.1111/1753-6405.12503 · Cited by 28
Nakas, A., Waller, D. A., Lau, K., Richards, C., & Muller, S. (2012) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezr251 · Cited by 28
Self-citationGirgis, S., Smith, A. B., Lambert, S., Waller, A. E., & Girgis, A. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-018-4357-0 · Cited by 28
DREAM: A phase II study of durvalumab with first line chemotherapy in mesothelioma—First results.
Nowak, A. K., Lesterhuis, W. J., Hughes, B. G. M., Brown, C. S. B., Kok, P., O'Byrne, K. J., John, T., Pavlakis, N., Kao, S., Yip, S., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.36.15_suppl.8503 · Cited by 28
den Borre, L. V., & Deboosere, P. (2014) · International Journal of Occupational and Environmental Health · doi:10.1179/2049396714y.0000000058 · Cited by 27
Mesothelioma Associated With Commercial Use of Vermiculite Containing Libby Amphibole
Dunning, K. K., Adjei, S., Levin, L. S., Rohs, A. M., Hilbert, T., Borton, E. K., Kapil, V., Rice, C. H., LeMasters, G. K., & Lockey, J. E. (2012) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e318250b5f5 · Cited by 26
Surveillance of mesothelioma and workers' compensation in British Columbia, Canada
Kirkham, T. L., Koehoorn, M. W., McLeod, C., & Demers, P. A. (2010) · Occupational and Environmental Medicine · doi:10.1136/oem.2009.048629 · Cited by 26
Glynn, M., Keeton, K. A., Gaffney, S. H., & Sahmel, J. E. (2017) · Risk Analysis · doi:10.1111/risa.12887 · Cited by 26
Krupoves, A., Camus, M., & Guire, L. D. (2015) · American Journal of Industrial Medicine · doi:10.1002/ajim.22442 · Cited by 25
Incidence and familial risk of pleural mesothelioma in Sweden: a national cohort study
Ji, J., Sundquist, J., & Sundquist, K. (2016) · European Respiratory Journal · doi:10.1183/13993003.00091-2016 · Cited by 25
Sheffield, B. S., Lorette, J., Shen, Y., Marra, M. A., & Churg, A. (2016) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2015-0508-le · Cited by 24
Malignant mesothelioma incidence by nation-wide cancer registry: a population-based study
Tómasson, K., Guðmundsson, G., Bríem, H., & Rafnsson, V. (2016) · Journal of Occupational Medicine and Toxicology · doi:10.1186/s12995-016-0127-4 · Cited by 24
Potency Factors for Risk Assessment at Libby, Montana
Moolgavkar, S. H., Turim, J., Alexander, D. D., Lau, E., & Cushing, C. A. (2010) · Risk Analysis · doi:10.1111/j.1539-6924.2010.01411.x · Cited by 23
Industrial pollution and pleural cancer mortality in Spain
López‐Abente, G., Fernández‐Navarro, P., Boldo, E., Ramis, R., & García‐Pérez, J. (2012) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2012.02.047 · Cited by 23
Soluble Markers for Diagnosis of Malignant Pleural Mesothelioma
Cristaudo, A., Bonotti, A., Simonini, S., Bruno, R., & Foddis, R. (2011) · Biomarkers in Medicine · doi:10.2217/bmm.11.18 · Cited by 23
Gómez, M. G., Navarro, A. M., & López, R. C. (2014) · International Journal of Occupational and Environmental Health · doi:10.1179/2049396714y.0000000087 · Cited by 19
Filiberti, R., Marroni, P., Spigno, F., Merlo, D. F., Mortara, V., Caruso, P., Cioè, A., Michelazzi, L., Bruzzone, A., Bobbio, B., et al. (2013) · Oncology · doi:10.1159/000355687 · Cited by 19
Cancer morbidity of residents living near an oil refinery plant in North-West Italy
Salerno, C., Berchialla, P., Palin, L. A., Vanhaecht, K., & Panella, M. (2012) · International Journal of Environmental Health Research · doi:10.1080/09603123.2012.733938 · Cited by 18
Radical multimodality therapy for malignant pleural mesothelioma
Abdel-Rahman, O. M., Elsayed, Z., Mohamed, H. H., & Eltobgy, M. M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012605 · Cited by 18
Berk, S., Yalcin, H., Dogan, O. T., Epozturk, K., Akkurt, I., & Seyfikli, Z. (2014) · Environmental Geochemistry and Health · doi:10.1007/s10653-013-9518-y · Cited by 17
Are airborne refractory ceramic fibers similar to asbestos in their carcinogenicity?
Walker, A. M., Maxim, L. D., & Utell, M. J. (2012) · Inhalation Toxicology · doi:10.3109/08958378.2012.683892 · Cited by 17
Abakay, A., Tanrıkulu, A. Ç., Ayhan, M., İmamoğlu, M. Ş., Taylan, M., Ma, K., & Abakay, Ö. (2015) · Environmental Health and Preventive Medicine · doi:10.1007/s12199-015-0501-3 · Cited by 17
Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994–2009
Jennings, C. J., Walsh, P. M., Deady, S., Harvey, B. J., & Thomas, W. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2013.12.002 · Cited by 16
Wei, B., Jia, X., Ye, B., Yu, J., Zhang, B., Zhang, X., Lu, R., Dong, T., & Yang, L. (2012) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/jes.2012.63 · Cited by 16
Fazzo, L., Menegozzo, S., Soggiu, M. E., Santis, M. D., Santoro, M. C., Cozza, V., Brangi, A., Menegozzo, M., & Comba, P. (2014) · Annali dell Istituto Superiore di Sanità · doi:10.4415/ann_14_04_05 · Cited by 15
Agostin, F. D., Michieli, P. D., & Negro, C. (2017) · International Journal of Occupational Medicine and Environmental Health · doi:10.13075/ijomeh.1896.00890 · Cited by 15
Time trends and spatial patterns in the mesothelioma incidence in Slovenia, 1961–2014
Zadnik, V., Žakelj, M. P., Jarm, K., & Žagar, T. (2017) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000384 · Cited by 15
Real-life treatment practice for malignant pleural mesothelioma in Belgium
Rosskamp, M., Macq, G., Nackaerts, K., Praet, M. M., Eycken, L. J. V., van Meerbeeck, J. P., & Schutter, H. D. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.10.009 · Cited by 15
Conti, S., Minelli, G., Manno, V., Iavarone, I., Comba, P., Scondotto, S., & Cernigliaro, A. (2014) · Annali dell Istituto Superiore di Sanità · doi:10.4415/ann_14_02_04 · Cited by 14
Borelli, V., de Moura, R. R., Trevisan, E., & Crovella, S. (2015) · Infectious Agents and Cancer · doi:10.1186/s13027-015-0022-0 · Cited by 12
Current efforts in research of pleural mesothelioma—An analysis of the ClinicalTrials.gov registry
Süveg, K., Putora, P. M., Berghmans, T., Glatzer, M., Kovac, V., & Čihorić, N. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.07.007 · Cited by 12
Self-citationKüçüköner, M., Ma, K., İnal, A., Urakçı, Z., Abakay, Ö., Tanrıkulu, A. Ç., Abakay, A., Şen, H. S., Türkçü, G., Şenyiğit, A., et al. (2014) · Journal of B.U.ON. : official journal of the Balkan Union of Oncology · Cited by 11
Regional differences in incidence of malignant mesothelioma in Denmark.
Skammeritz, E. M. L., Omland, Ø., Hansen, J., & Johansen, J. P. (2013) · PubMed · Cited by 11
Langhoff, M. D., Kragh-Thomsen, M. B., Stanislaus, S., & Weinreich, U. M. (2014) · Danish Medical Journal · Cited by 11
Trends in mesothelioma mortality rates in South Africa: 1995–2007
Kielkowski, D., Nelson, G., Bello, B., Kgalamono, S. M., & Phillips, J. I. (2011) · Occupational and Environmental Medicine · doi:10.1136/oem.2010.062182 · Cited by 11
Abakay, A., Tanrıkulu, A. Ç., İmamoğlu, M. Ş., Ayhan, M., Taylan, M., Ma, K., & Abakay, Ö. (2016) · Environmental Health and Preventive Medicine · doi:10.1007/s12199-016-0508-4 · Cited by 11
Malignant mesothelioma in Metsovo, Greece, from domestic use of asbestos: 30 years later: Figure 1–
Gogali, A., Manda-Stachouli, C., Ntzani, E., Matthaiou, M., Konstantinidis, A. K., Zampira, I., Koubaniou, C., Dalavanga, Y., Stefanou, D., Constantopoulos, S. H., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00017011 · Cited by 10
Habib, E. E., & Fahmy, E. S. (2013) · Clinical & Translational Oncology · doi:10.1007/s12094-013-1015-3 · Cited by 9
Incidence of malignant mesothelioma in New Zealand and Australia: a global snapshot.
Mj, S., & van Zandwijk, N. (2015) · PubMed · Cited by 6
Mesothelioma trends in the ACT and comparisons with the rest of Australia
Korda, R., Clements, M., Armstrong, B. K., Trevenar, S. M., Chalker, E., Newman, L., & Kirk, M. (2016) · Public Health Research & Practice · doi:10.17061/phrp2641646 · Cited by 5
Marsh, G. M., & Benson, S. M. (2016) · Occupational and Environmental Medicine · doi:10.1136/oemed-2016-104002 · Cited by 5
Cited by
Baas, P., Scherpereel, A., Nowak, A. K., Fujimoto, N., Peters, S., Tsao, A. S., Mansfield, A. S., Popat, S., Jahan, T., Antonia, S., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32714-8 · Cited by 1,215
Self-citationUpdate on biology and management of mesothelioma
Asciak, R., George, V., & Rahman, N. M. (2021) · European Respiratory Review · doi:10.1183/16000617.0226-2020 · Cited by 75
The Immune Microenvironment of Malignant Pleural Mesothelioma: A Literature Review
Désage, A.-L., Karpathiou, G., Peoc’h, M., & Froudarakis, M. E. (2021) · Cancers · doi:10.3390/cancers13133205 · Cited by 34
Metadata
- Authors
- Scherpereel, A., Opitz, I., Berghmans, T., Psallidas, I., Glatzer, M., Rigau, D., Astoul, P., Bölükbas, S., Boyd, J., Coolen, J., De Bondt, C., De Ruysscher, D., Durieux, V., Faivre-Finn, C., Fennell, D., Galateau-Salle, F., Greillier, L., Hoda, M. A., Klepetko, W., Lacourt, A., McElnay, P., Maskell, N. A., Mutti, L., Pairon, J.-C., Van Schil, P., van Meerbeeck, J. P., Waller, D., Weder, W., Cardillo, G., & Putora, P. M.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2020-05-25
- Volume
- 55
- Issue
- 6
- Pages
- 1900953
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W3028094831
- Cited by
- 273
- References
- 285
- FWCI
- 20.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.